medigraphic.com
ISSN 1561-2945 (Print)

2014, Number 2

<< Back

Revista Cubana de Cirugía 2014; 53 (2)

Oligometastases and oligo-recurrence of lung cancer, are they conditions pointing to death?

García RME, Armas PB, Armas MK, Álvarez EG

Language: Spanish
References: 39
Page: 213-225
PDF size: 130.78 Kb.


ABSTRACT

The metastatic non-small-cell lung cancer patients have a poor prognosis. Present debates discuss a group of these patients with synchronous or metachronous lesions that can survive for a long period of time after removing the primary lesion, and its metastases of cerebral and adrenal location in vast majority. In this regard, an extensive literature review focused on the metastatic condition of the non small cell lung cancer was made. Databases such as Pubmed, Medline, Ebsco, Cochrane and Redalyc were consulted and scientific evidence on this topic was analyzed. It was concluded that metastases and recurrences found in patients suffering pulmonary cancer have been considered as conditions pointing to death. These patients have been treated with systemic therapies as a group. The surgery remains a therapeutic option, reinforcing the theory of “the seed and the soil"


REFERENCES

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. Mar-Apr 2011;61:69-90.

  2. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20-37.

  3. Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol. 2012;7(8):1246-51.

  4. García Rodríguez ME, Armas Pérez BA, Armas Moredo K. Actualización en el tratamiento del cáncer pulmonar de células no pequeñas en etapa IIIA con afectación N2. Rev Cubana Cir [revista en la Internet]. 2012 Sep [citado 2013 Jun 03];51(3):217-33. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003474932012000300003&lng=es

  5. Pfannschmidt J, Dienemann H. Surgical treatment of oligometastatic non-small cell lung cancer. Lung Cancer. 2010;69(3):251-8.

  6. García Rodríguez ME, Armas Pérez BA, Armas Moredo K. Oligorecurrencia a partir de un adenocarcinoma del pulmón. Utilidad de la resección. Arch Bronconeumol. 2014;50:46-7.

  7. García Rodríguez ME. Estadificación y valoración mediastínica del cáncer del pulmón. Rev Cubana Cir [revista en la Internet]. 2010 Dic [citado 2013 Jun 03];49(4):82-93. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003474932010000400012&lng=es

  8. Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, et al. Surgical treatment for non-small cell lung cancer with ipsilateral pulmonary metastases. Surg Today. 2013;43(10):1123-8.

  9. Shiovitz S, Eaton KD. A 66-year-old woman with newly diagnosed oligometastatic non-small cell lung cancer. J Natl Compr Canc Netw. 2012;10(3):297-301.

  10. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606-12.

  11. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98-101.

  12. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453-8.

  13. Fidler IJ. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am. 2001;10(2):257-69.

  14. Niibe Y, Hayakawa K. Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol. 2010;40(2):107-11.

  15. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10.

  16. Ishigaki T, Yoshimasu T, Oura S, Ota F, Nakamura R, Hirai Y, et al. Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer. Ann Thorac Cardiovasc Surg. 2013;19(5):341-4.

  17. De Ruysscher D, Wanders R, van Baardwijk A, Dingemans AM, Reymen B, Houben R, et al. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol. 2012; 7(10):1547-55.

  18. Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. Chest. 2011;140(6):1494-502.

  19. Kang Y. New tricks against an old foe: molecular dissection of metastasis tissue n tropism in breast cancer. Breast Dis. 2006;26:129-38.

  20. Weichselbaum RR, Hellman S. Oligometastases revisited. Nature reviews Clinical oncology. 2011;8(6):378-82.

  21. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679-95.

  22. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, Landreneau RJ, et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol. 2011;29(32):4313-9.

  23. Yilmaz A, Duyar SS, Cakir E, Aydin E, Demirag F, Karakaya J, et al. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2011;40(3):664-70.

  24. Schuchert MJ, Schumacher L, Kilic A, Close J, Landreneau JR, Pennathur A, et al. Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I nonsmall cell lung cancer. Ann Thorac Surg. 2011;91(4):1059-65.

  25. Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer. 1988;61(10):2083-8.

  26. Niibe Y, Chang JY, Onishi H, Salama J, Hiraki T, Yamashita H. Oligometastases/Oligo-recurrence of lung cancer. Pulmonary Medicine. [Internet]. Mar. 2013 [citado 26 Ene 2013]; Article ID 438236:[aprox. 3 p.]. Disponible en: http://dx.doi.org/10.1155/2013/438236

  27. Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, et al. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012;379(9818):823-32.

  28. Patel MI, Wakelee HA. Adjuvant chemotherapy for early stage non-small cell lung cancer. Frontiers in oncology. 2011;1:45.

  29. Osarogiagbon RU, Allen JW, Farooq A, Wu JT. Objective review of mediastinal lymph node examination in a lung cancer resection cohort. J Thorac Oncol. 2012;7(2):390-6.

  30. Osarogiagbon RU. Predicting survival of patients with resectable non-small cell lung cancer: Beyond TNM. Journal of Thoracic Disease. 2012;4(2):214-6.

  31. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409-17.

  32. Ziyade S, Pinarbasili NB, Ziyade N, Akdemir OC, Sahin F, Soysal O, et al. Determination of standard number, size and weight of mediastinal lymph nodes in postmortem examinations: reflection on lung cancer surgery. J Cardiothorac Surg. 2013;8:94.

  33. De Ruysscher D, Wanders R, van Baardwijk A, Dingemans AM, Reymen B, Houben R, et al. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol. 2012; 7(10):1547-55.

  34. Toyooka S, Kiura K, Shien K, Katsui K, Hotta K, Kanazawa S, et al. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of nonsmall- cell lung cancer patients with pathological mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg. 2012;15(6):954-60.

  35. Congedo MT, Cesario A, Lococo F, De Waure C, Apolone G, Meacci E, et al. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience. J Thorac Cardiovasc Surg. 2012; 144(2):444-52.

  36. Bonnette P. [Non-small cell lung cancer with oligometastases: treatment with curative intent]. Cancer Radiother. 2012;16(5-6):344-7.

  37. García Rodríguez Miguel Emilio. La resección pulmonar y disección mediastinal a través de la esternotomía media. AMC [revista en la Internet]. 2013 Feb [citado 2014 Feb 04]; 17(1):13-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025 02552013000100005&lng=es.

  38. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10(8):972-92.

  39. Hamaji M, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Wigle DA, et al. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013;145(3):683-90.




2020     |     www.medigraphic.com